Abstract
Induction chemotherapy plus radiotherapy followed by surgery, evaluated in a number of phase II studies, is an effective treatment for patients with stage III A non-small cell lung cancer (NSCLC). The ongoing phase III National Cancer Institute Intergroup study is evaluating concurrent chemotherapy (cisplatin + etoposide)/radiotherapy followed by either surgery or additional radiotherapy followed by 2 additional cycles of chemotherapy in patients with stage III A disease. This study will help define the role of surgery and radiotherapy as part of the multimodality therapy of locoregional advanced NSCLC.
Similar content being viewed by others
References
Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi ATIII, Weick JK, Longhyna VA, Presant CA, McKenna RJ, Gandara DR (1995) Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage III A (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group phase III study 8805. J Clin Oncol 13:1880
Burkes R, Ginsberg RJ, Sheperd F, Blackstein ME, Goldberg ME, Waters PF, Patterson A, Todd T, Pearson FG, Cooper JD, Jones D, Lockwood G(1992) Induction chemotherapy with mitomycin, vindesine and cisplatin for stage III unresectable non-small cell lung cancer: results of the Toronto phase II trial. J Clin Oncol 10:580
Faber LP, Kittle CF, Warren WH, Bonomi PD, Taylor SG, Reddy S, Lee MS (1989) Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg 47:669
Green MR, Lilenbaum RC (1994) Stage IIIA category of non-small cell lung cancer: a new proposal. J Natl Cancer Inst 86:586
Ihde DC, Minna JD (1991) Non-small cell lung cancer part one: biology, diagnosis and staging. Curr Probl Cancer 15:63
Martini N, Kris MG, Flehinger FJ, Gralla RJ, Bains MS, Burt ME, Heelan R, McCormack PM, Pisters KM, Rigas JR (1993) Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 55:365
Mountain CF(1986) A new international staging system for lung cancer. Chest 89:225s
Mountain CF (1997) Revision in the international system for staging lung cancer. Chest 111:171
Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics 1997. CA Cancer J Clin 47:5
Pass HI, Pogrebniak HW, Steinberg SM, Mulshine J, Minna J (1992) Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 53:992
Recine D, Rowland K, Reddy S, Lee MS, Bonomi P, Taylor SIV, Faber LP, Warren W, Kittle F, Hendrickson FR (1990) Combined modality therapy for locally advanced non-small cell lung carcinoma. Cancer 66:2270
Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Cantó A, Mate JL, Li S, Roig J, Olazábel A, Canela M, Ariza A, Skácel Z, Morera-Prat J, Abad A (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 33:153
Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, Dhingra H, De Caro L, Chasen M, McGavran M (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III non-small cell lung cancer. J Natl Cancer Inst 86:673
Skarin A, Jochelson M, Sheldon T, Malcolm A, Oliynyk P, Overholt R, Hunt M, Frei E III (1989) Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: long-term follow-up in 41 patients. J Surg Oncol 40:266
Strauss GM, Herndon JE, Sherman DD, Mathisen DJ, Carey RW, Choi NC, Rege VB, Modeas C, Green MR (1992) Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 10:1237
Weiden PL, Piantadosi S for the Lung Cancer Study Group (1991) Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non- small cell lung cancer: phase II study of the LCSG. J Natl Cancer Inst 83:66
Author information
Authors and Affiliations
Additional information
Work presented at the 13th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium, “Strategic Cross Talk between Major Oncology Groups/Clinical Pharmacology in Cancer Chemotherapy”, 17–18 October 1997, Nagoya, Japan
Rights and permissions
About this article
Cite this article
Ettinger, D.S. Combined-modality treatment for stage IIIa (n2) non-small cell lung cancer: a national cancer institute intergroup study. Cancer Chemother Pharmacol 42 (Suppl 1), S71–S74 (1998). https://doi.org/10.1007/s002800051083
Issue Date:
DOI: https://doi.org/10.1007/s002800051083